BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10682010)

  • 1. Concordance between use of proton pump inhibitors and prescribing guidelines.
    Pillans PI; Kubler PA; Radford JM; Overland V
    Med J Aust; 2000 Jan; 172(1):16-8. PubMed ID: 10682010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing of proton pump inhibitors for gastrointestinal bleeding prophylaxis in the Lebanese outpatient setting: patterns, compliance with guidelines and risks.
    Soubra L; Issa M
    Int J Pharm Pract; 2019 Aug; 27(4):386-392. PubMed ID: 30942513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital.
    Luo H; Fan Q; Xiao S; Chen K
    BMC Health Serv Res; 2018 Jul; 18(1):537. PubMed ID: 29996830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inappropriate use of proton pump inhibitors.
    Molloy D; Molloy A; O'Loughlin C; Falconer M; Hennessy M
    Ir J Med Sci; 2010 Mar; 179(1):73-5. PubMed ID: 19763673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A questionnaire on prescription patterns of proton pump inhibitors for hemodialysis patients in Japan.
    Kawarazaki H; Nakashima A; Furusho M; Shimizu S; Nakata T
    Clin Exp Nephrol; 2020 Jun; 24(6):565-572. PubMed ID: 32147803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescribing efficiency of proton pump inhibitors in China: influence and future directions.
    Zeng W; Finlayson AE; Shankar S; de Bruyn W; Godman B
    BMC Health Serv Res; 2015 Jan; 15():11. PubMed ID: 25609265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change.
    Ramser KL; Sprabery LR; Hamann GL; George CM; Will A
    J Manag Care Pharm; 2009 May; 15(4):344-50. PubMed ID: 19422274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors: a study of GPs' prescribing.
    Jones MI; Greenfield SM; Jowett S; Bradley CP; Seal R
    Fam Pract; 2001 Jun; 18(3):333-8. PubMed ID: 11356744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescribing Patterns of Proton Pump Inhibitors in Germany: A Retrospective Study Including 472 146 Patients.
    Plehhova K; Haering M; Wray J; Coyle C; Ibáñez E; Kostev K
    J Prim Care Community Health; 2023; 14():21501319231221002. PubMed ID: 38142444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors for prophylaxis of nosocomial upper gastrointestinal tract bleeding: effect of standardized guidelines on prescribing practice.
    Yachimski PS; Farrell EA; Hunt DP; Reid AE
    Arch Intern Med; 2010 May; 170(9):779-83. PubMed ID: 20458085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Study of Off-label Proton Pump Inhibitor Use Among New Zealand Infants in the First Year of Life (2005-2012).
    Blank ML; Parkin L
    J Pediatr Gastroenterol Nutr; 2017 Aug; 65(2):179-184. PubMed ID: 28403034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori and dyspepsia: physicians' attitudes, clinical practice, and prescribing habits.
    O'Connor HJ
    Aliment Pharmacol Ther; 2002 Mar; 16(3):487-96. PubMed ID: 11876702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
    Lucas LM; Gerrity MS; Anderson T
    Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the NIH Consensus Conference on Helicobacter pylori on physician prescribing among a Medicaid population.
    Thamer M; Ray NF; Henderson SC; Rinehart CS; Sherman CR; Ferguson JH
    Med Care; 1998 May; 36(5):646-60. PubMed ID: 9596056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overuse of proton pump inhibitors.
    Naunton M; Peterson GM; Bleasel MD
    J Clin Pharm Ther; 2000 Oct; 25(5):333-40. PubMed ID: 11123484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Validity of proton pump inhibitors' prescriptions in a department of internal medicine].
    Marie I; Moutot A; Tharrasse A; Hellot MF; Robaday S; Hervé F; Lévesque H
    Rev Med Interne; 2007 Feb; 28(2):86-93. PubMed ID: 17092611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid suppressants for managing gastro-oesophageal reflux and gastro-oesophageal reflux disease in infants: a national survey.
    Bell JC; Schneuer FJ; Harrison C; Trevena L; Hiscock H; Elshaug AG; Nassar N
    Arch Dis Child; 2018 Jul; 103(7):660-664. PubMed ID: 29472195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Survey of the prescriptions of proton pump inhibitors in patients admitted in an internal medicine ward: how is the compliance to the French guidelines?].
    Sauvaget L; Rolland L; Dabadie S; Desblaches J; Bernard N; Vandenhende MA; Bonnet F; Pédeboscq S; Morlat P
    Rev Med Interne; 2015 Oct; 36(10):651-7. PubMed ID: 26051189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the prescription of proton pump inhibitors in persons aged 75years and older in a geriatric acute-care unit].
    Dipanda M; Pioro L; Buttard M; d'Athis P; Asgassou S; Putot S; Deïdda M; Laborde C; Putot A; Manckoundia P
    Therapie; 2017 Dec; 72(6):669-675. PubMed ID: 28939010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing the cost of proton pump inhibitors by adopting best practice.
    Hughes JD; Tanpurekul W; Keen NC; Ee HC
    Qual Prim Care; 2009; 17(1):15-21. PubMed ID: 19281670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.